Dr. Hundal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 Medical Center Dr
Nashville, TN 37232
Summary
- Amrita Hundal, MD is an Assistant Professor of Clinical Medicine in the Department of Medicine, Division of General Internal Medicine and Public Health at Vanderbilt University School of Medicine. She earned her Bachelor of Science in Cellular Biology and Molecular Genetics from the University of Maryland, College Park and her Doctorate of Medicine from the American University of the Caribbean. Dr. Hundal completed her Internal Medicine residency at Eastern Virginia Medical School after beginning her training at Nassau University Medical Center.
Dr. Hundal is the Chief Medical Officer of Techsensus, a healthcare technology company improving care delivery and patient outcomes. In this role, she leads clinical strategy and initiatives, including physician support for Indian Health Services to enhance care access for underserved Native American populations.
Dr. Hundal’s research background includes biodefense vaccination development, where she collaborated with the Walter Reed Army Institute of Research (WRAIR) and the U.S. Naval Research Laboratory on projects aimed at combating bioterrorism threats.
With extensive clinical experience, Dr. Hundal has worked as a hospitalist with US Acute Care Solutions and Sound Physicians, an intensivist with MedStar Health, and a telemedicine provider with Amwell. She is actively involved in quality improvement initiatives, serving on committees addressing workplace violence prevention and catheter-associated urinary tract infection (CAUTI) reduction.
Dr. Hundal has presented on diverse medical topics, including women’s health issues, and co-authored a peer-reviewed publication on dermatologic side effects of targeted cancer therapies.
Board-certified in Internal Medicine and licensed in multiple states, Dr. Hundal is dedicated to physician advocacy, public health, and advancing patient safety.
Education & Training
- Eastern Virginia Medical SchoolResidency, Internal Medicine, 2017 - 2019
- Nassau University Medical CenterInternship, Internal Medicine, 2016 - 2017
- American University of the Caribbean School of MedicineClass of 2016
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MD State Medical License 2019 - 2026
- TN State Medical License 2024 - 2026
- VA State Medical License 2017 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
Journal Articles
- Rash Associated with Ibrutinib Therapy for Chronic Lymphocytic LeukemiaAmrita Hundal, Journal of Skin Diseases, 2/11/2017
Committees
- Physician Advocate, Workplace Violence Committee 2024 - Present
- Physician, CAUTI Committee 2023 - Present
- Physician, Antibiotic Stewardship 2019 - 2021
Research History
- Bioterrorism Vaccine DevelopmentPerformed advanced enzyme kinetics and protein purifications of Venezuelan and Western Equine Encephalitis Viruses, as well as Ebola, with an end goal of affective vaccine production for the United States Naval Bioterrorism Lab2010 - 2016
Other Languages
- Punjabi, Hindi, Urdu, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: